Most Accessed Articles

Biological Drugs in Guillain-Barré Syndrome: An Update

, 2017; 15(7): 938-950.

Nazgol Motamed-Gorji*, Nassim Matin, Omidreza Tabatabaie, Piero Pavone, Catia Romano, Raffaele Falsaperla and Giovanna Vitaliti

DOI: 10.2174/1570159X14666161213114904

Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications

, 2017; 15(7): 1032-1042.

Rainer Kraehenmann*

DOI: 10.2174/1573413713666170619092629

The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind

, 2017; 15(6): 926-935.

Roberta Ricciarelli* and Ernesto Fedele*

DOI: 10.2174/1570159X15666170116143743

Beyond Ketamine: New Approaches to the Development of Safer Antidepressants

, 2017; 15(7): 963-976.

Shigeyuki Chaki*

DOI: 10.2174/1570159X15666170221101054

The Infectious Etiology of Alzheimer’s Disease

, 2017; 15(7): 996-1009.

Marta Sochocka *, Katarzyna Zwolińska and Jerzy Leszek

DOI: 10.2174/1570159X15666170313122937

Mechanisms of Melatonin in Alleviating Alzheimer’s Disease

, 2017; 15(7): 1010-1031.

Mayuri Shukla, Piyarat Govitrapong*, Parichart Boontem, Russel J. Reiter and Jutamaad Satayavivad

DOI: 10.2174/1570159X15666170313123454

From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis

, 2017; 15(6): 874-891.

Lilian Aly, Bernhard Hemmer* and Thomas Korn*

DOI: 10.2174/1570159X14666161208151525

The Challenge of microRNA as a Biomarker of Epilepsy

, 2018; 16(1): 37-42.

Yihong Ma *

DOI: 10.2174/1570159X15666170703102410

Opioids and the Blood-Brain Barrier: A Dynamic Interaction with Consequences on Drug Disposition in Brain

, 2017; 15(8): 1156-1173.

Catarina Chaves, Fernando Remiao, Salvatore Cisternino and Xavier Decleves*

DOI: 10.2174/1570159X15666170504095823

The Progress of Epilepsy after Stroke

, 2018; 16(1): 71-78.

Yinghao Zhao, Xiangyan Li, Kun Zhang, Ti Tong* and Ranji Cui*

DOI: 10.2174/1570159X15666170613083253

Webmaster Contact:
Copyright © 2018 Bentham Science